Atropine sulfate is an anticholinergic medication used to treat bradycardia and increase heart rate. It works by blocking the effects of acetylcholine at parasympathetic nerve sites, primarily muscarinic receptors. This inhibits secretions and relaxes smooth muscles. Atropine is indicated to decrease oral and respiratory secretions during surgery and for hemodynamically significant bradycardia or asystole. Common adverse effects include drowsiness, confusion, blurred vision, and tachycardia. Nurses should instruct patients to take atropine as directed and monitor for signs of overdose.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Atropine sulfate is an anticholinergic medication used to treat bradycardia and increase heart rate. It works by blocking the effects of acetylcholine at parasympathetic nerve sites, primarily muscarinic receptors. This inhibits secretions and relaxes smooth muscles. Atropine is indicated to decrease oral and respiratory secretions during surgery and for hemodynamically significant bradycardia or asystole. Common adverse effects include drowsiness, confusion, blurred vision, and tachycardia. Nurses should instruct patients to take atropine as directed and monitor for signs of overdose.
Atropine sulfate is an anticholinergic medication used to treat bradycardia and increase heart rate. It works by blocking the effects of acetylcholine at parasympathetic nerve sites, primarily muscarinic receptors. This inhibits secretions and relaxes smooth muscles. Atropine is indicated to decrease oral and respiratory secretions during surgery and for hemodynamically significant bradycardia or asystole. Common adverse effects include drowsiness, confusion, blurred vision, and tachycardia. Nurses should instruct patients to take atropine as directed and monitor for signs of overdose.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Atropine sulfate is an anticholinergic medication used to treat bradycardia and increase heart rate. It works by blocking the effects of acetylcholine at parasympathetic nerve sites, primarily muscarinic receptors. This inhibits secretions and relaxes smooth muscles. Atropine is indicated to decrease oral and respiratory secretions during surgery and for hemodynamically significant bradycardia or asystole. Common adverse effects include drowsiness, confusion, blurred vision, and tachycardia. Nurses should instruct patients to take atropine as directed and monitor for signs of overdose.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
EFFECTS CONSIDERATION Atropine Therapeutic: Atropine sulfate is a Given Tachycardia. Drowsiness, Instruct patient to sulfate antiarrhyth potent operatively confusion, take as directed. mics parasympatholytic. It to Hypersensitivity. blurred vision, Take missed inhibits actions of decrease tachycardia, doses as soon as Pharmacolog acetylcholine at oral and Unstable palpitations, remembered ic: postganglionic respiratory cardiovascular dry mouth, unless almost anticholinerg parasympathetic secretions. status in acute constipation, time for next ics, neuroeffector sites, hemorrhage urinary dose. Do not antimuscarin primarily at muscarinic Hemodyna with myocardial hesitancy, double doses. ics receptors. Small doses mically ischemia. retention. inhibit salivary and significant May cause bronchial secretions, bradycardi drowsiness. moderate doses dilate a. Caution patients pupils and increase to avoid driving heart rate. Large doses Asystole. or other activities decrease GI motility, requiring inhibit gastric acid alertness until secretion. Blocked response to vagal effects result in medication positive chronotropy known. and positive dromotropy (limited or no inotropic effect). In emergency care, it is primarily used to increase the heart rate in life-threatening bradycardias. Dose/Administration
Bradydysrhythmias Adult 0.5 – 1.0 mg IV, may be repeated at 5 min intervals until desired rate achieved. (max 0.03-0.04mg/kg) Pediatric 0.02 mg/kg IV, IO, ET(diluted to 3-5ml). Min dose 0.1mg; max single dose fo 0.5 mg for a child and 1.0 mg for an adolescent; may be repeated in 5 minutes for a max total fo 1.0 mg for a child and 2.0 mg for an adolescent.
Asystole Adult 1.0 mg IV, ET, (1-2 mg diluted to a total of 10ml); may be repeated every 3-5 minutes (max 0.03 – 0.04mg/kg) Pediatric unknown efficacy
PEA Adult 1 mg IV (if bradycardic), repeat every 3-5 minutes, max 0.03 – 0.04mg/kg. Pediatric unknown efficacy
Anticholinesterase Poisoning Adult 2 mg IV push every 5-15 minutes to dry secretions. No max dose. Pediatric 0.05 mg/kg/dose (usual dose 1-5 mg) IV, may be repeated in 15 minutes.
